Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
176,391,745
-
Total 13F shares
-
151,052,849
-
Share change
-
+42,790,470
-
Total reported value
-
$528,694,287
-
Put/Call ratio
-
0%
-
Price per share
-
$3.50
-
Number of holders
-
124
-
Value change
-
+$149,920,554
-
Number of buys
-
73
-
Number of sells
-
41
Institutional Holders of Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CMPX) as of Q3 2025
As of 30 Sep 2025 Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CMPX) had 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 151,052,849 shares of stock of the company.
Largest 10 holders included TANG CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, Blackstone Inc., Vivo Capital, LLC, ENAVATE SCIENCES GP, LLC, BlackRock, Inc., VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., and MPM BIOIMPACT LLC.
This table shows 124 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.